KEAP1
Lysine-specific demethylase 6A | |
---|---|
Identifiers | |
Symbol | ? |
HGNC | 11031 |
KDM6A, also known as lysine-specific demethylase 6A, is a gene that encodes a protein involved in the regulation of gene expression through the demethylation of histone proteins. This protein is part of the Jumonji C (JmjC) domain-containing family of histone demethylases, which play a critical role in the epigenetic regulation of chromatin structure and function.
Function[edit | edit source]
KDM6A is responsible for the demethylation of tri-methylated lysine 27 on histone H3 (H3K27me3), a key epigenetic mark associated with transcriptional repression. By removing this methyl group, KDM6A activates gene expression by altering chromatin structure, making it more accessible to transcriptional machinery. This process is crucial for various cellular processes, including differentiation, development, and the maintenance of stem cell pluripotency.
Structure[edit | edit source]
The KDM6A protein contains several important domains, including the JmjC domain, which is essential for its demethylase activity. The protein also has tetratricopeptide repeat (TPR) domains that facilitate protein-protein interactions, allowing KDM6A to form complexes with other proteins involved in chromatin remodeling.
Clinical Significance[edit | edit source]
Mutations in the KDM6A gene have been implicated in several human diseases. Notably, KDM6A is associated with Kabuki syndrome, a rare genetic disorder characterized by distinctive facial features, growth delays, and intellectual disabilities. Additionally, KDM6A mutations have been identified in various cancers, including bladder cancer and multiple myeloma, where they may contribute to tumorigenesis by disrupting normal epigenetic regulation.
Research and Therapeutic Potential[edit | edit source]
Given its role in epigenetic regulation, KDM6A is a target of interest for therapeutic intervention. Inhibitors of KDM6A and related demethylases are being explored as potential treatments for cancers and other diseases where dysregulation of histone methylation is a factor. Understanding the precise mechanisms by which KDM6A influences gene expression and cellular function remains an active area of research.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD